Although some claims were dismissed, the majority remain part of the MDL, ensuring that the litigation proceeds under a unified process
While beneficial, rapid weight reduction can lead to nutritional deficiencies in some patients
Key information to disclose includes: Medication name and dose "I take Wegovy (semaglutide) 2.4 mg once weekly by subcutaneous injection" Duration of treatment how long you have been taking Wegovy and whether you are still in the dose-escalation phase Current side effects any ongoing nausea, vomiting, diarrhoea, dizziness, or other symptoms Reason for prescription whether prescribed for obesity alone or with comorbidities such as type 2 diabetes, hypertension, or cardiovascular disease Overall health status current weight, blood pressure, and general wellbeing Donation staff will ask about your medical history and may need to consult with medical advisors regarding Wegovy
Sun Damage Ultraviolet (UV) radiation breaks down collagen and elastin over time
Active Ingredient Semaglutide 0.5 mg per dose Uses Management of type 2 diabetes mellitus in adults